Thromb Haemost 1985; 54(02): 463-465
DOI: 10.1055/s-0038-1657873
Original Article
Schattauer GmbH Stuttgart

Reactivity of Small Molecular Forms of Human Factor VIII/von Willebrand Factor with Botrocetin and Anti-Factor VIII-Coated Latex Particles

M Furlan
The Central Hematology Laboratory, Inselspital, Berne, Switzerland
,
B A Perret
The Central Hematology Laboratory, Inselspital, Berne, Switzerland
,
E A Beck
The Central Hematology Laboratory, Inselspital, Berne, Switzerland
› Author Affiliations
Further Information

Publication History

Received 29 June 1984

Accepted 14 May 1985

Publication Date:
18 July 2018 (online)

Summary

Two recently developed tests for measurement of factor VIII/von Willebrand factor (FVIII/vWF), i.e. platetelet agglutination by botrocetin and a kinetic latex antigen assay, were compared with ristocetin cofactor and electroimmunoassay, in respect with FVIII/vWF size-distribution. FVIII/vWF was measured in six cases of atypical von Willebrand’s disease (type II), in gel-filtered fractions of normal cryoprecipitate and in the course of depolymerization of purified normal FVIII/vWF by disulfide reduction. Small molecular forms of FVIII/vWF from normal and variant type II plasma, and those derived by disulfide reduction of high-molecular weight FVIII/vWF, showed remarkably decreased reactivity in ristocetin-, botrocetin- and latex-assay. We conclude that for botrocetin-induced platelet agglutination, as well as for agglutination of antibody-coated latex particles, multiple interactions with repeating subunits of FVIII/vWF are required. As a practical consequence, the combined measurement of FVIII/vWF by the latex test and electroimmunoassay provides a simple tool for discriminating between the classical von Willebrand’s disease and its variants.

 
  • References

  • 1 Perret EA, Furlan M, Beck EA. Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers. Biochim Biophys Acta 1979; 578: 164-174
  • 2 Brinkhous KM, Read MS, Fricke WA, Wagner RH. Botrocetin (venom coagglutinin): Reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci USA 1983; 80: 1463-1466
  • 3 Howard MA, Perkin J, Salem HH, Firkin BG. The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane. Br J Haematol 1984; 57: 25-35
  • 4 Crane LJ. Kinetic latex agglutinometry II: A rapid, quantitative assay for factor VIII antigen. Clin Chem 1981; 27: 697-700
  • 5 Furlan M, Perret BA, Beck EA. Von Willebrand activity of low molecular weight human factor VIII increases by binding to gold granules. Thromb Haemostas 1981; 45: 242-246
  • 6 Perret BA, Felix R, Furlan M, Beck EA. Silver staining of high molecular weight proteins on large-pore polyacrylamide gels. Analyt Biochem 1983; 131: 46-50
  • 7 Hoyer L, Shainoff JR. Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers. Blood 1980; 55: 1056-1059
  • 8 Peake IR, Bloom AL. The use of an immunoradiometric assay for factor VIII related antigen in the study of atypical von Willebrand’s disease. Thromb Res 1977; 10: 27-32
  • 9 Ardaillou N, Girma JP, Meyer D, Lavergne JM, Shoa’i I, Larrieu MJ. “Variants” of von Willebrand“s disease. Demonstration of a decreased antigenic reactivity by immunoradiometric assay. Thromb Res 1978; 12: 817-830
  • 10 Weis JW, Nelson D. Factor VIII related antigen in variant von Willebrand’s disease. Thromb Res 1984; 33: 457-459
  • 11 Short PE, Williams CE, Enayat MS, Picken AM, Hill FGH. Lack of correlation between factor VIII related antigen multimeric analysis pattern and parallel or non-parallel dose response curves in an ELISA factor VIII related antigen assay. J Clin Pathol 1984; 37: 194-199